Skip to main content
. 2022 Sep 27;24(5):412. doi: 10.3892/ol.2022.13532

Figure 7.

Figure 7.

(A) Association between SPARC gene expression and survival prognosis in patients with LUAD. (B) The relationship between copy number variation in LUAD and immune cell infiltration. (C) Association between SPARC gene expression and survival prognosis in patients with LUSC. (D) The relationship between copy number variation in LUSC and immune-cell infiltration. *P<0.05; **P<0.01; ***P<0.001 vs. diploid/normal immune cells. SPARC, secreted protein acidic and cysteine rich; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.